Clinical trial
Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining…
NCT00321737 · Takeda, Industry · Completed
Key facts
| NCT number | NCT00321737 |
|---|---|
| Title | Efficacy and Safety of Dexlansoprazole MR Compared to Placebo on Maintaining Healing in Subjects With Healed Erosive Esophagitis |
| Official title | A Phase 3 Study to Evaluate the Safety and Efficacy of TAK-390MR (30 mg QD and 60 mg QD) Compared to Placebo in Maintenance of Healing in Subjects With Healed Erosive Esophagitis. |
| Lead sponsor | Takeda, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Esophagitis, Reflux, Peptic |
| Intervention type | Drug |
| Interventions | Dexlansoprazole MR, Placebo |
| Enrollment | 445 |
| Start date | May 1, 2006 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | May 4, 2006 |
| Last update posted | Feb 3, 2012 |
| Countries | Australia, Canada, Czechia, Estonia, Latvia, Lithuania, Slovakia, United States |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: